438 Current news

rss
matching the following criteria

Thermo Fisher Scientific and Samsung Electronics to Collaborate on Point-of-Care Diagnostic Solutions

26-11-2014

To answer the healthcare industry’s demand for better point-of-care (POC) diagnostics, Thermo Fisher Scientific Inc. and Samsung Electronics Co., Ltd. have formed a strategic collaboration. The companies will jointly design, develop and market new POC solutions in key applications, such as the ...

more

QIAGEN announces broad agreement with Astellas Pharma to develop companion diagnostics

First two programs aim to create tests to aid in cancer treatment with Astellas compounds under development

30-10-2014

QIAGEN N.V. announced a master collaboration agreement with Astellas Pharma Inc. to develop and commercialize companion diagnostics paired with Astellas drugs for use in cancer and other diseases. The scope of the agreement is not restricted to certain sample types, platforms, indications or ...

more

Yale University and Leica Microsystems Partner to Establish Microscopy Center of Excellence

01-10-2014

On Monday, October 20, 2014, Yale University West Campus will open the doors to a new microscopy Center of Excellence made possible through a partnership with Leica Microsystems. Housed in a newly created core facility, the Leica Center of Excellence at Yale West Campus will provide scientists ...

more

GENALICE and deCODE Genetics enter into a partnership for population wide genomic analysis

28-07-2014

GENALICE announced it is partnering with deCODE Genetics to facilitate the large-scale testing of its unique DNA data processing software solution, GENALICE MAP. After a first successful round of evaluating GENALICE MAP on speed and quality, both parties agreed to extend the evaluation to include ...

more

Evotec receives first milestone in Roche biomarker collaboration

25-04-2014

Evotec AG announced the successful achievement of a milestone in its biomarker alliance with Roche. The milestone was achieved on the decision by Roche to use a response prediction marker, identified using Evotec's Proteome Profiling platform, in an extended phase I oncology trial. This is the ...

more

Polyplus-transfection and the National Institute of Health sign a research license agreement

19-02-2014

Polyplus-transfection SA announces that it has granted two agencies of the United States National Institutes of Health (“NIH”) a non-exclusive, research license to use Polyethylenimine (PEI) for in vitro transfection applications. The two agencies are the National Institute of Allergy and ...

more

MolecularHealth Partners with GATC Biotech for Genetic Sequencing Technology and Expertise

14-01-2014

MolecularHealth announced a unique agreement with GATC Biotech. GATC Biotech will provide protocols, support and extensive training of MolecularHealth’s laboratory staff. Additionally, MolecularHealth will use GATC Biotech’s LIMS (Laboratory Information Management System) in itsnewly opened ...

more

Lonza signs exclusive agreement with Index Ventures

Five year agreement includes all companies where Index Ventures will be the majority shareholder

13-01-2014

Lonza and Index Ventures, LLP announced an exclusive agreement for process development and cGMP production for all biological products in the portfolio of companies where Index is the major investor. Over the course of the agreement, additional development and manufacturing projects will be added ...

more

Evonik and LanzaTech working on bio-processed precursors for specialty plastics

11-12-2013

Evonik Industries and LanzaTech have signed a three year research cooperationagreement which will see Evonik combining its existing biotechnology platforms with LanzaTech’s synthetic biology and gas fermentation expertise for the development of a route to bioprocessed precursors for specialty ...

more

Roche and Molecular Partners enter into alliance

Partnership will combine novel biologics (DARPins) with Roche drug-conjugate technology

05-12-2013

Roche and Molecular Partners AG announced that they have entered into a research collaboration and licensing agreement to discover, develop and commercialize several proprietary therapeutics incorporating Molecular Partners’ DARPin® biologics conjugated to toxic agents developed at Roche for the ...

more

Page 1 From 44
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE